Taiwan Food and Drug Administration (TFDA) has officially become one of the ICH pharmaceutical Regulatory Member at the International Council for Harmonization (ICH) Assembly meeting at Kobe, Japan, 7th June 2018. This set a new milestone for our participations in the international pharmaceutical and technical collaborations. This would not only boost the developments of our pharmaceutical industries, but also promote the wellbeing of our people.

ICH was founded in April 1990 by the representatives of the regulatory authorities and industry associations from Europe, Japan and the US. The goal is to promote public health through international harmonization of the technical requirements for the pharmaceuticals. TFDA has been joining ICH related events for more than 10 years since 2008. We not only attended regular ICH Assemblies, but also participated in more than twenty expert working groups. In addition, we held training courses for the industries so they could learn and follow the latest ICH guidelines. Becoming the Regulatory Member of ICH has significant meanings to TFDA as we have been working diligently to improve our regulatory environment and follow the international guidelines. This also shows that our pharmaceutical products possess very high quality, and have been recognized by international standards.

In the future, TFDA will continue to actively participate in the ICH related events to construct a regulatory environment that complies with the ICH guidelines. Through the collaborations between government and industry, high-quality drugs could be manufactured. Thus our people’s wellbeing can be assured.